Literature DB >> 10435492

Animal models of tremor.

H Wilms1, J Sievers, G Deuschl.   

Abstract

Animal models of tremor have been widely used in experimental neurology, because they are an indispensable requirement for understanding the pathophysiology of human tremor disorders and the development of new therapeutic agents. This review focuses on three approaches to produce tremor in animals (application of tremorgenic drugs, experimental central nervous system lesions, study of genetic mutants) and their use in simulating tremor syndromes of humans. Whereas harmaline induces a postural/kinetic tremor in animals that shares some features with human essential tremor/enhanced physiological tremor, MPTP tremor is the best model available for rest tremor in people. The tremor following experimental lesion of the ventromedial tegmentum in primates closely resembles Holmes tremor in humans, whereas cerebellar intention tremor is mimicked by cooling of the lateral cerebellar nuclei. The "campus syndrome," discovered in a breed of Pietrain pigs, might be a useful model of human orthostatic tremor. However, no animal model has yet been generated that exactly recreates all features of any of the known tremor disorders in humans. Problems encountered when comparing tremor in animals and humans include differing tremor frequencies and the uncertainty, if specific transmitter abnormalities/central nervous system lesions seen in animal tremor models are characteristic for their human counterparts. The search for adequate tremor models continues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435492     DOI: 10.1002/1531-8257(199907)14:4<557::aid-mds1004>3.0.co;2-g

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

1.  Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive.

Authors:  Young-Gyun Park; Hye-Yeon Park; C Justin Lee; Soonwook Choi; Seonmi Jo; Hansol Choi; Yang-Hann Kim; Hee-Sup Shin; Rodolfo R Llinas; Daesoo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

Review 2.  Differential diagnosis of common tremor syndromes.

Authors:  R Bhidayasiri
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

3.  Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study.

Authors:  V Caretti; D Stoffers; A Winogrodzka; I-U Isaias; G Costantino; G Pezzoli; C Ferrarese; A Antonini; E-Ch Wolters; J Booij
Journal:  J Neural Transm (Vienna)       Date:  2008-03-12       Impact factor: 3.575

4.  Frequency-dependent functional neuromodulatory effects on the motor network by ventral lateral thalamic deep brain stimulation in swine.

Authors:  Seungleal B Paek; Hoon-Ki Min; Inyong Kim; Emily J Knight; James J Baek; Allan J Bieber; Kendall H Lee; Su-Youne Chang
Journal:  Neuroimage       Date:  2014-10-14       Impact factor: 6.556

5.  Consensus paper: Decoding the Contributions of the Cerebellum as a Time Machine. From Neurons to Clinical Applications.

Authors:  Martin Bareš; Richard Apps; Laura Avanzino; Assaf Breska; Egidio D'Angelo; Pavel Filip; Marcus Gerwig; Richard B Ivry; Charlotte L Lawrenson; Elan D Louis; Nicholas A Lusk; Mario Manto; Warren H Meck; Hiroshi Mitoma; Elijah A Petter
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

6.  The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease.

Authors:  Zixiu Xiang; Analisa D Thompson; John T Brogan; Michael L Schulte; Bruce J Melancon; Debbie Mi; L Michelle Lewis; Bende Zou; Liya Yang; Ryan Morrison; Tammy Santomango; Frank Byers; Katrina Brewer; Jonathan S Aldrich; Haibo Yu; Eric S Dawson; Min Li; Owen McManus; Carrie K Jones; J Scott Daniels; Corey R Hopkins; Ximin Simon Xie; P Jeffrey Conn; C David Weaver; Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2011-12-21       Impact factor: 4.418

7.  Genetic mouse models of essential tremor: are they essential?

Authors:  Joseph Jankovic; Jeffrey L Noebels
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

8.  Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.

Authors:  Chao Wu; Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2009-05-13       Impact factor: 5.858

9.  Balance and motor speech impairment in essential tremor.

Authors:  Martin Kronenbuerger; Jürgen Konczak; Wolfram Ziegler; Paul Buderath; Benedikt Frank; Volker A Coenen; Karl Kiening; Peter Reinacher; Johannes Noth; Dagmar Timmann
Journal:  Cerebellum       Date:  2009-05-19       Impact factor: 3.847

10.  Personality in essential tremor: further evidence of non-motor manifestations of the disease.

Authors:  A Chatterjee; E C Jurewicz; L M Applegate; E D Louis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.